What is aTyr Pharma's shares (diluted)?

aTyr Pharma (ATYR) reported shares (diluted) of 98M in Q1 2026.

How has aTyr Pharma's shares (diluted) changed year-over-year?

aTyr Pharma's shares (diluted) increased by 13.4% year-over-year, from 86.5M to 98M.

What is the long-term trend for aTyr Pharma's shares (diluted)?

Over 4 years (2021 to 2025), aTyr Pharma's shares (diluted) has grown at a 52.7% compound annual growth rate (CAGR), from 67.5M to 366.7M.

What does shares (diluted) mean?

The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

aTyr Pharma ATYR Shares (Diluted)

Shares (Diluted) at other companies

United TherapeuticsUTHR

47.2M-2.9%

Design Therapeutics, Inc.DSGN

61.4M+8.2%

Vor BiopharmaVOR

43M+589%

Oric Pharmaceuticals, Inc.ORIC

105.5M+48.5%

Rigel PharmaceuticalsRIGL

19.7M+8.3%

Syndax PharmaceuticalsSNDX

88.3M+2.4%

Other financials

Income statement

See full

Revenue-—

Operating income-$11.4M+27.5%

Net income-$10.8M+27.5%

EPS (diluted)-$0.11+35.3%

Balance sheet

See full

Cash & equivalents$10.0M-3.4%

Total debt$12.3M-9.2%

Total equity$57.9M-22.8%

Total assets$79.7M-18.1%

Cash flow

See full

Operating cash flow-$12.5M+18.8%

CapEx$138.0K—

Free cash flow-$12.7M+17.9%

Valuation

See full

Market cap$54.88M-88.2%

Enterprise value$57.17M—

P/S288.8×—

Profitability

See full

Operating margin-40,856.3%+28,833pp

Net margin-39,009.5%+29,653pp

FCF margin-32,664.7%+4,018pp

Returns & leverage

See full

Return on equity-105.3%+50.6pp

Debt / equity0.2×0.0×

Current ratio5.8×-2.0×

Where this comes from

Reported directly by aTyr Pharma in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: aTyr Pharma’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about aTyr Pharma's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is aTyr Pharma's shares (diluted)?: aTyr Pharma (ATYR) reported shares (diluted) of 98M in Q1 2026.
How has aTyr Pharma's shares (diluted) changed year-over-year?: aTyr Pharma's shares (diluted) increased by 13.4% year-over-year, from 86.5M to 98M.
What is the long-term trend for aTyr Pharma's shares (diluted)?: Over 4 years (2021 to 2025), aTyr Pharma's shares (diluted) has grown at a 52.7% compound annual growth rate (CAGR), from 67.5M to 366.7M.
What does shares (diluted) mean?: The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.